Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Genzyme

This article was originally published in The Gray Sheet

Executive Summary

Genzyme: Plans to debut its EndoValve heart valve surgical instruments for use during stopped heart procedures this fall, John Gilsdorf, executive VP-surgical products said at a June 19 Dillon, Read & Co. Medical Technology meeting in New York City. The instruments were developed under an agreement with mechanical heart valve maker CarboMedics ("The Gray Sheet" Jan. 13, I&W-7). Genzyme also plans a third quarter introduction of a mechanical heart stabilizer that can affix to a retractor, and a combined visualization telescope and hand held retractor for video-assisted redo sternotomy...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008319

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel